Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change how we prevent disease, age, and define human potential. The same tools ...

Gameto plans to integrate this meiosis-induction approach with its proprietary ovarian organoid (“ovaroid”) platform to ...

Modern therapeutics are shifting from their reliance on small molecules to biologics produced by cultured cells. The development and production of those biologics increasingly rely on computationally ...

“The Role of Synthetic Biology in the Realization of the Bioeconomy” is the title of the talk that Carrie Eckert, leader of the Synthetic Biology Group at Oak Ridge National Laboratory, will present ...